These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9455049)

  • 1. [Antibacterial sensitivity, phage group and coagulase type of Staphylococcus aureus isolated from bullous impetigo].
    Kagami K; Murakami M; Takeshita S
    Kansenshogaku Zasshi; 1997 Nov; 71(11):1108-12. PubMed ID: 9455049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on staphylococcal coagulase type and phage type isolated from pyodermas, especially impetigo contagiosa].
    Uragami K
    Nihon Hifuka Gakkai Zasshi; 1983 May; 93(6):613-27. PubMed ID: 6225887
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991).
    Nishijima S; Namura S; Mitsuya K; Asada Y
    J Dermatol; 1993 Apr; 20(4):193-7. PubMed ID: 8315107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of bullous impetigo caused by Staphylococcus aureus strains of phage type 3C/71 in a maternity ward linked to nasal carriage of a healthcare worker.
    Piechowicz L; Garbacz K; Budzyńska A; Dąbrowska-Szponar M
    Eur J Dermatol; 2012; 22(2):252-5. PubMed ID: 22378195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Producibility of exfoliative toxin and staphylococcal coagulase types of Staphylococcus aureus strains isolated from skin infections and atopic dermatitis.
    Kanzaki H; Ueda M; Morishita Y; Akiyama H; Arata J; Kanzaki S
    Dermatology; 1997; 195(1):6-9. PubMed ID: 9267729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan.
    Takizawa Y; Taneike I; Nakagawa S; Oishi T; Nitahara Y; Iwakura N; Ozaki K; Takano M; Nakayama T; Yamamoto T
    J Clin Microbiol; 2005 Jul; 43(7):3356-63. PubMed ID: 16000460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epidemiological study of methicillin-resistant Staphylococcus aureus (MRSA) isolated from medical staff, inpatients, and hospital environment in one ward at our hospital.
    Nishijima S; Sugimachi T; Higashida T; Asada Y; Okuda K; Murata K
    J Dermatol; 1992 Jun; 19(6):356-61. PubMed ID: 1401489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance of Staphylococcus aureus isolated from impetigo patients between 1994 and 2000.
    Nishijim S; Ohshima S; Higashida T; Nakaya H; Kurokawa I
    Int J Dermatol; 2003 Jan; 42(1):23-5. PubMed ID: 12581136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of antibacterials of Staphylococcus aureus isolated from impetigo patients.
    Nishijima S; Nakagawa M
    J Int Med Res; 1997; 25(4):210-3. PubMed ID: 9283995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus.
    Murono K; Fujita K; Yoshioka H
    Pediatr Infect Dis J; 1988 May; 7(5):313-5. PubMed ID: 3380582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homology of Staphylococcus aureus isolated from skin lesions and nose of patients with impetigo].
    Li YZ; Ma L; Kong FR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):10-2. PubMed ID: 19317048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
    Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current options for the treatment of impetigo in children.
    Sladden MJ; Johnston GA
    Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1990 Jun; 43(6):919-53. PubMed ID: 2122040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological studies on drug-resistance patterns, coagulase types, and MRSA-phage types of MRSA isolates during 1990-1994].
    Nakae M; Sugahara Y; Sasaki H; Yasui H; Imai C; Hasegawa Y; Osaka K; Sibasaki K; Nashimoto M
    Jpn J Antibiot; 1999 Apr; 52(4):313-21. PubMed ID: 10396688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.